Onivyde pegylated liposomal : Orphan maintenance assessment report - post authorisation (II-34)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
orphan-maintenance-report-post
medication.label.permit_number
EMA/OD/0000144740
medication.label.permit_validity
First published: 2024-05-17T13:06:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live